Connor, Clark & Lunn Investment Management (CC&L)
AURA icon

Connor, Clark & Lunn Investment Management (CC&L)’s Aura Biosciences AURA Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-18,364
Closed -$151K – 1399
2024
Q4 		$151K Sell
18,364
-28,987
-61% -$273K ﹤0.01% 1347
2024
Q3 		$422K Sell
47,351
-11,704
-20% -$100K ﹤0.01% 1141
2024
Q2 		$446K Sell
59,055
-12,631
-18% -$92.5K ﹤0.01% 1081
2024
Q1 		$563K Buy
71,686
+58,764
+455% +$487K ﹤0.01% 1070
2023
Q4 		$114K Buy
+12,922
New +$109K ﹤0.01% 1310

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s AURA Position: Q1 2025 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Aura Biosciences (AURA) in Q1 2025, closing a stake of 18,364 shares — an estimated $151K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in AURA in Q4 2023 and held it in 5 quarters. The position peaked at $563K in Q1 2024. 94 funds tracked by Wall St. Rank hold AURA as of Q1 2025.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Aura Biosciences position as of Q1 2025 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 18,364 Aura Biosciences shares in Q1 2025, an estimated $151K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Aura Biosciences in Q4 2023 and held it in 5 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Aura Biosciences position peaked at $563K in Q1 2024.
  • 94 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2025.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2025, filed 12 May 2025.